New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

This year, drug companies have been living under a cloud of uncertainty created by the Trump administration. Threats of tough ...

Concurrent use of menopausal hormone therapy may augment the weight loss benefits of tirzepatide for postmenopausal women ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Most of the scariest side effects of weight-loss drugs like Ozempic, Wegovy, and Zepbound have been gastrointestinal.